Stocks to watch: Paytm, Zen Technologies, Suven Pharma, Lupin, RVNL, and Ahluwalia Contracts shares in focus

2 months ago 17

GE T&D, RVNL, and Ahluwalia Contracts shares will be in focus due to securing significant orders. Meanwhile, Zen Technologies launched four AI-powered defense products. Lupin’s Dabhasa facility received USFDA approval. Suven Pharma acquired a majority stake in Sapala Organics. Softbank Vision Fund exited Paytm read more

 Paytm, Zen Technologies, Suven Pharma, Lupin, RVNL, and Ahluwalia Contracts shares in focus

A man looks at a screen displaying news of markets update inside the Bombay Stock Exchange (BSE) building in Mumbai. File image/Reuters

The GIFT Nifty index, around 8:50 am on Monday (July 15), hinted at a positive start for Dalal Street. It was up 67.5 points or 0.27 per cent at 24,613.5. The India VIX, an indicator of volatility in the market, was down 1.93 per cent at 13.72 points.  

Global cues remained largely positive. In the US, on Friday (July 12), the markets closed higher, with the Dow Jones climbing 0.62 per cent to settle near record levels, while the Nasdaq rose 0.63 per cent and the S&P 500 gained 0.55 per cent. Asian markets, on Monday morning, displayed a mixed performance.

Ahead of the market opening on Monday, here’s a look at stocks to watch:

GE T&D India: GE T&D has received of order from Power Grid Corporation of India Limited for Supply, Installation, Testing, Commissioning and Maintenance of SCADA/EMS Control Centres. The value of the order is Rs 490 crore.

Zen Technologies: Zen Technologies, in collaboration with its subsidiary AI Turing Technologies based in Pune, launched four new products on Monday. the products– Hawkeye, Barbarik-URCWS (Ultralight Remote Control Weapon Station), Prahasta, and Sthir Stab 640– are AI-powered robots aimed for the global defence market.

Lupin: Lupin received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located in Dabhasa, Gujarat. The EIR was issued after the facility’s last inspection conducted from April 8 to April 12.

Suven Pharma: Suven Pharmaceuticals has acquired 51 per cent of the share capital on a fully diluted basis (i.e., 67.5 per cent of the present equity share capital) of Sapala Organics Private Limited.

Ahluwalia Contracts: The company has received an order worth Rs 581 crore for Civil & Structural work at “The Edition” Sector-66, Gurugram (Haryana) from ETSY Realcon.

RVNL: Rail Vikas Nigam secured a Letter of Acceptance (LoA) for a project worth Rs 132.6 crore from Central Railway for OHE modification work in Nagpur division.

Paytm: According to a report by PTI, Japan-based Softbank Vision Fund, exited from Paytm in the June quarter at a loss of around $150 million.

Read Entire Article